首页|单采血浆频次与献浆者骨密度和骨代谢相关性研究

单采血浆频次与献浆者骨密度和骨代谢相关性研究

扫码查看
目的 了解单采血浆捐献者血清骨代谢生化标志物水平以及骨密度情况,为保障我国单采血浆捐献者健康安全提供科学依据。方法 招募2022年7月1日-9月30日湖南省临武单采血浆站437名单采血浆捐献者,测定捐献者血清总钙、白蛋白、血清25-羟基维生素D(25OHD)、血清I型原胶原N-端前肽(P1NP)、1型胶原交联羧基端肽(β-CTX)水平。采用双能X射线法对单采血浆捐献者腰椎前后位(L1-L4)骨密度、双侧股骨颈骨密度进行测量。将单采血浆捐献者按照献浆类型(新献浆者和重复献浆者)分组来评估各组间骨密度以及血清骨代谢生化标志物水平的差异。采用限制性立方样条分析献浆总次数与生化指标间的剂量反应关系,并对有显著影响的指标通过多重线性回归进行影响因素的探究。结果 本研究共纳入437名研究对象,其中新献浆者187名,重复献浆者250名。新献浆者与重复献浆者两组之间不同部位骨密度及骨质疏松患病率差异均无统计学意义(P>0。05)。与新献浆者组相比,重复献浆者白蛋白及25OHD水平更低,P1NP水平更高,且均具有统计学差异。限制性立方样条结果表明,献浆总次数与25OHD及P1NP均呈非线性剂量反应关系(P<0。05)。多重线性回归结果表明,献浆频次与25OHD水平呈负相关,献浆总次数与P1NP水平呈正相关。结论 单采血浆捐献不会因为长期抗凝剂的使用而影响献浆者的骨骼健康以及增加骨质疏松的风险,但会增加献浆者体内成骨活动。建议中老年献浆者适当补充维生素D。
Bone density and bone metabolism in plasmapheresis donors
Objective To investigate the level of serum bone metabolism and biochemical markers and bone densi-ty of plasmapheresis donors,and to provide scientific basis for ensuring the health and safety of plasmapheresis donors in China.Methods A total of 437 plasmapheresis donors from Linwu plasmapheresis station in Hunan Province from July 1 to September 30,2022 were recruited to determine the levels of total serum calcium,albumin,serum 25-hy-droxyvitamin D(25OHD),serum type Ⅰ procollagen N-terminal propeptide(P1NP),and collagen type 1 crosslinked carboxy l-terminal peptide(β-CTX).Dual-energy X-ray method was used to measure the bone density of the anteroposte-rior lumbar spine(L1-L4)and bilateral femoral neck bone density of plasmapheresis donors.Plasmapheresis donors were grouped according to the type of plasma donation(first-time and repeat plasmapheresis donors)and the total num-ber of plasma donations to assess the differences in bone density and serum bone metabolism biochemical markers be-tween groups.The dose-response relationship between the total number of plasmapheresis donations and biochemical in-dexes was analyzed by limiting cubic spline,and the influencing factors of different indexes were explored by multiple linear regression.Results A total of 437 plasmapheresis donors were included in this study,including 187 first-time plasmapheresis donors and 250 repeat plasmapheresis donors.There were no significant differences in bone density and prevalence of osteoporosis between first-time donors and repeat donors(P>0.05).There was also no significant differ-ence in bone density levels between groups of total number of plasmapheresis donations.The levels of albumin and 25OHD decreased with the increase of the total number of plasma donations,while the serum P1NP level was positively correlated with the total number of plasma donations.The results of the restriction cubic spline showed that the total num-ber of plasmapheresis donations had a nonlinear dose-response relationship with 25OH and P1NP(P<0.05).The results of multiple linear regression showed that the frequency of plasmapheresis donation was the influencing factor of 25OHD,and the total number of plasmapheresis donation was the influencing factor of P1NP.Conclusion Plasmapher-esis donation does not affect the bone health of donors and increase the risk of osteoporosis due to the use of long-term anticoagulants,but it will increase the osteogenic activity of plasmapheresis donors.It is recommended that middle-aged and elderly plasmapheresis donors supplement vitamin D appropriately.

plasmapheresisbone mineral densitymarkers of bone turnoverosteoporosis

李婉、李长清、陈勇军、阳希、黎志伟、王娅

展开 >

中国医学科学院北京协和医学院输血研究所,四川成都 610052

南岳生物制药有限公司

南岳生物临武单采血浆站有限公司

单采血浆 骨密度 骨转换标志物 骨质疏松症

中国医学科学院医学与健康科技创新工程重大协同创新项目

2021-I2M-1-060

2024

中国输血杂志
中国输血协会 中国医学科学院输血研究所

中国输血杂志

CSTPCD
影响因子:1.279
ISSN:1004-549X
年,卷(期):2024.37(1)
  • 22